SCHEMBL5495682

SCHEMBL5495682

Nc1ccc(C#Cc2ccccc2)c(C(F)(F)F)c1.Nc1ccc(C#Cc2ccccc2)c(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
TSHR P16473 2/20 0.47
GLA P06280 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
NPC1 O15118 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
FFAR1 O14842 2/20 0.43
APP P05067 2/20 0.40
PTPN1 P18031 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31095607 1.00 MAPT (0.50) MAPTTSHRGLAPOLBGAA
SCHEMBL5501538 1.00 MAPT (0.50) MAPTTSHRGLAPOLBGAA
SCHEMBL4970196 0.89 TSHR (0.46) MAPTTSHRGLAPOLBGAA
SCHEMBL27970953 0.79 FFAR1 (0.55) MAPTTSHRGLAPOLBGAA
SCHEMBL3275176 0.78 MAPT (0.61) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL563999 0.78 FFAR1 (0.60) MAPTTSHRNPC1KDM4EMEN1
SCHEMBL7531908 0.77 MAPT (0.59) MAPTTSHRPOLBNPC1KDM4E
SCHEMBL6865700 0.76 FFAR1 (0.49) NPC1FFAR1PTPN1HAO1RAB9A
SCHEMBL31095611 0.74 CASP3 (0.48) MAPTPOLBNPC1MEN1ALDH1A1
SCHEMBL15544149 0.74 MAPT (0.55) MAPTTSHRGAANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 EP disclosed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 WO disclosed